Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,966.20
+301.50 (18.11%)
Last updated: Oct 22, 2026, 3:29 PM IST
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 19.98 billion as of October 22, 2026. It is the 20,295th most valuable company in the world and the 1,231st biggest in India. Its market cap has increased by 8.73% in one year.
Market Cap
19.98B
Enterprise Value
20.21B
Revenue
4.10B
Global Rank
Country Rank
#1,231 India
PE Ratio
44.37
ChartMarket Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 19.98B, an increase of 2,081.24%. That is a compound annual growth rate of 40.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 19.98B | 27.77% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 45.32B |
| Solara Active Pharma Sciences | 31.15B |
| Ind-Swift Laboratories | 30.60B |
| Indoco Remedies | 21.83B |
| Sakar Healthcare | 20.54B |
| Windlas Biotech | 18.70B |
| Jagsonpal Pharmaceuticals | 14.35B |
| Anlon Healthcare | 14.33B |